KSHV positive cell lines

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 9133, 435372, 4742291, C12N 700, A61K 39245

Patent

active

059087730

ABSTRACT:
The invention provides a cell line comprising Kaposi's sarcoma-associated herpesvirus (KSHV). Preferably, the cell line is a body cavity-based lymphoma cell line, and more preferably, the cell line does not harbor Epstein-Barr virus. Two cell lines designated BC-2 and BC-3 are thus provided. These cell lines can be used in a method of propagating KSHV. The method comprises culturing the cell line, wherein the KSHV within the cell line thereby propagates. The BC-3 cell line, in particular, can be used in a method of propagating KSHV in the absence of Epstein-Barr virus. The method comprises culturing the cell line designated BC-3, wherein the KSHV within the cell line thereby propagates. Further provided is a purified viral suspension of KSHV, as well as a composition comprising purified KSHV and a suitable carrier.

REFERENCES:
Chang, et al, 1994, Science, vol. 266, pp. 1865-1869.
Cesarman et al, 1995, Blood, vol. 86, pp. 2708-2714.
Boshoff et al, 1995, Nature Medicine, vol. 1, pp. 1274-1278.
Foreman et al, 1997, N.E.J.M., vol. 336, pp. 163-171.
Rennie et al, 1996, Nature Med., vol 2, pp. 342-346.
Nador, et al., "Herpes-Like DNA Sequences in a Body-Cavity-Based Lymphoma in the HIV-Negative Patient," The New England Journal of Medicine, 333(14):943 (1995) (abstract).
Walts, et al., "Diagnosis of Malignant Lymphoma in Effusions from Patients with AIDS by Gene Rearrangement," A.J.C.P., 94(2):170-75 (1990).
Green, et al., "Primary Lymphomatous Effusions in AIDS: A Morphological, Immunophenotypic, and Molecular Study," Modern Pathology, 8(1):39-45 (1995).
Lin, et al., "Precision of Genotyping of Epstein-Barr Virus by Polymerase Chain Reaction Using Three Gene Loci (EBNA-2, EBNA-3C, and EBER): Predominance of Type A Virus Associated With Hodgkin's Disease," Blood, 81(12):3372-81 (1993).
Chadburn, et al., "CD30 (Ki-1) Positive Anaplastic Large Cell Lymphomas in Individuals Infected With the Human Immunodeficiency Virus," Cancer, 72(10):3078-90 (1993).
Knowles, et al., "Molecular Genetic Analysis of Three AIDS-Associated Neoplasms of Uncertain Lineage Demonstrates Their B-Cell Derivation and the Possible Pathogenic Role of the Epstein-Barr Virus," Blood, 73(3):792-99 (1989).
Biesinger, et al., "Stable Growth Transformation of Human T Lymphocytes by Herpesvirus saimiri," Immunology, 89:3116-19 (1992).
Mesri, et al., "Human Herpesvirus-8/Kaposi's Sarcoma-Associated Herpesvirus is a New Transmissible Virus That Infects B Cells," J. Exp. Med., 183:2385-90 (1996).
Baer et al., "DNA Sequence and Expression of the B95-8 Epstein-Barr Virus Genome," Nature, 310:207-211 (1984).
Cameron et al., "The 160,000-M.sub.r Virion Protein Encoded at the right End of the Herpesvirus Saimiri Genome Is Homologous to the 140,000-M.sub.r Membrane Antigen Encoded at the Left End of the Epstein-Barr Virus Genome," Journal of Virology, 61:2063-2070 (1987).
Albrecht et al., "Primary Structure of the Herpesvirus Saimiri Genome," Journal of Virology, 66:5047-5058 (1992).
Nicholas et al., "Herpesvirus Saimiri Encodes Homologues of G Protein-Coupled Receptors and Cyclins," Nature, 355:362-365 (1992).
Ambroziak et al., "Herpes-Like Sequences in HIV-Infected and Uninfected Kaposi's Sarcoma Patients," Science, 268:582-583 (1995).
Boshoff et al., "Kaposi's-Sarcoma-Associated Herpesvirus In HIV-Negative Kaposi's Sarcoma," The Lancet 345:1043-1044 (1995).
Cesarman et al., "Kaposi's Sarcoma-Associated Herpesvirus-Like DNA Sequences in Aids-Related Body-Cavity-Based Lymphomas," The New England Journal of Medicine, 332:1186-1191 (1995).
Dupin et al., New England Journal of Medicine, p. 798 (1995).
Dupin et al., "Herpesvirus-Like DNA Sequences In Patients With Mediterranean Kaposi's Sarcoma," The Lancet, 345:761-762 (1995).
Karcher et al., "Herpes-Like DNA Sequences, Aids-Related Tumors, and Castleman's Disease," The New England Journal of Medicine, 333:797-798 (1995).
Moore et al., "Detection of Herpesvirus-Like DNA Sequences in Kaposi's Sarcoma in Patients With and Those Without HIV Infection," The New England Journal of Medicine, 332:181-191 (1995).
Noel, "Kaposi's Sarcoma and KSHV," The Lancet, 346:1359 (1995).
Schalling et al., "A Role For A New Herpes Virus (KSHV) In Different Forms of Kaposi's Sarcoma," Nature Medicine, 1:707-708 (1995).
Shingadia et al., "Kaposi's Sarcoma and KSHV," The Lancet, 346:1359-1360 (1995).
Soulier et al., "Kaposi's Sarcoma-Associates Herpesvirus-Like Sequences In Multicentric Castleman's Disease," Blood, 86:1276-1280 (1995).
Whitby et al., "Detection of Kaposi Sarcoma Associated Herpesvirus in Peripheral Blood of HIV-Infected Individuals and Progression to Kaposi's Sarcoma," The Lancet, 346:799-802 (1995).
Gessain et al., "Kaposi Sarcoma-Associated Herpes-Like Virus (Human Herpesvirus Type 8) DNA Sequences in Multicentric Castleman's Disease: Is There Any Relevant Association In Non-Human Immunodeficiency Virus-Infected Patients?," Blood, pp. 414-418 (1996).
Arvanitakis, et al., "Establishment and Characterization of a Body Cavity-Based Lymphoma Cell Line (BC-3) Harboring Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in the Absence of Epstein-Barr Virus," Blood 88(7):001-007 (1996).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

KSHV positive cell lines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with KSHV positive cell lines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and KSHV positive cell lines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-954614

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.